We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend ...

Shares of AbbVie Inc. ABBV shed 2.90% to $171.68 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

A recent selloff of Neurocrine Biosciences stock feels unwarranted and may have created a contrarian buy opportunity. Learn ...

AbbVie Inc. has earned a spot among the elite Dividend Monarchs by raising dividends for 52 straight years—a feat worthy of a ...

Burdened by continuing troublesome inflation and cuts to federal health agencies, health care sector stocks are barely treading water. The S&P 500 Health Care Sector Index was fla ...

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug ...

BCC Research reveals in its new report, Alzheimer's Disease Therapeutics and Diagnostics: Global Markets, the market for Alzheimer's disease (AD) therapeutics and diagnostics is expected to grow from ...

The latest report published by Report Ocean, titled “Global Active Pharmaceutical Ingredients (API) Market“:Industry Trends, Share, Size, Growth, Opportunity, and Forecast 202 ...

The Global Prescription Drugs Market is valued at USD 1240.33 Billion in 2024 and is projected to reach a value of USD 2755 ...